Remove 2025 Remove Atherosclerosis Remove Hypertension
article thumbnail

Abstract WP56: Dental Flossing associated with reduced White Matter Hyperintensity and Intracranial Atherosclerosis

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP56-AWP56, February 1, 2025. Introduction:Prior studies have shown the association between oral infection, white matter hyperintensity (WMH), a marker of cerebral small vessel disease (CSVD), and asymptomatic intracranial atherosclerosis (ICAS). CSVD was assessed using the log of WMH volume.

article thumbnail

Your Top Five Questions About CMHC On-Demand, Answered

Cardiometabolic Health Congress

On-demand access is available now and will remain open until December 2025. Dyslipidemia, Atherosclerosis & Thrombosis: Explore non-statin therapies, strategies for managing hypertriglyceridemia, and new guidance on lipoprotein(a) management. When Will It Be Available? Ready to Access CMHC On-Demand?

CME 52
article thumbnail

Abstract WP260: The Role of Fibrinogen in the Pathogenesis of Intracranial Atherosclerosis-Related Large Vessel Occlusion Strokes

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP260-AWP260, February 1, 2025. Background:The mechanisms by which intracranial atherosclerosis (ICAS) contributes to large-vessel occlusion strokes (LVOS) remains unclear. Among patients with lower fibrinogen levels (< 3.2g/L),

article thumbnail

Abstract WP292: Efficacy of Lipid-Lowering Therapies in Reducing Stroke Risk in Intracranial Atherosclerosis: A Systematic Review and Meta-Analysis

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP292-AWP292, February 1, 2025. Background:Intracranial atherosclerosis (ICAS) is a common stroke cause, with a recurrent stroke risk of up to 18% per year despite treatment advances. Hypertension was present in 74% of the intervention group and 71% of controls. months (IQR 9.75-25.5).

article thumbnail

Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

Keynote speaker and atherosclerosis expert Peter Libby, MD , captivated the audience with an update on his research into inflammation and atherosclerosis. He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovascular disease. Learn more now!

CME 64
article thumbnail

Abstract WP293: The Effect of Selective Serotonin Reuptake Inhibitors on Stroke Risk in Migraine

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP293-AWP293, February 1, 2025. The HR was nonsignificant after adjustment for age, gender, race, hypertension, diabetes, hypercholesterolemia and smoking status, adjusted HR 1.33 The HR remained significant after adjustment for age, gender and race, adjusted HR 1.72 with a 95% CI of 1.17-2.51.

Stroke 40
article thumbnail

Abstract WP281: Optimizing Transthoracic Echocardiography Utilization for Hospitalized Ischemic Stroke Patients

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP281-AWP281, February 1, 2025. The model consisted of six variables, and one point was awarded for each: atrial fibrillation, large artery atherosclerosis, large vessel occlusion, obesity, prior anti-hypertensive medication usage and if patients age was 18-39 or > 69.